CMV terminase inhibitor

This page covers all CMV terminase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CMV terminase (UL56 protein complex), CMV UL56 terminase.

Targets

CMV terminase (UL56 protein complex) · CMV UL56 terminase

Marketed (1)

• Letermovir for secondary prophylaxis · Institute of Hematology & Blood Diseases Hospital, China · Infectious Disease / Virology
  Letermovir inhibits the cytomegalovirus (CMV) terminase complex, preventing viral DNA packaging and replication.

Phase 3 pipeline (1)

• Letermovir IV · Merck Sharp & Dohme LLC · Infectious Disease / Virology
  Letermovir inhibits the viral terminase enzyme of cytomegalovirus (CMV), preventing viral DNA packaging and replication.